Clinical trial

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

NCT00532272

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Letrozole ,Goserelin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE2

Conditions

Metastatic Breast Cancerunresolved

Interventions

Letrozole ,GoserelinDRUG

Sponsors & collaborators

National Cancer Center, Korealead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00532272 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.